4-chloro-7-nitrobenzofurazan has been researched along with palmitic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pagano, RE; Salman, M | 1 |
An, SY; Choi, SE; Ha, ES; Han, SJ; Kang, Y; Kim, DJ; Kim, HJ; Kim, TH; Lee, KW; Lee, MS | 1 |
2 other study(ies) available for 4-chloro-7-nitrobenzofurazan and palmitic acid
Article | Year |
---|---|
Use of a fluorescent analog of CDP-DAG in human skin fibroblasts: characterization of metabolism, distribution, and application to studies of phosphatidylinositol turnover.
Topics: 4-Chloro-7-nitrobenzofurazan; Cells, Cultured; Chromatography, Thin Layer; Cyclohexanones; Cytidine Diphosphate Diglycerides; Enzyme Inhibitors; Fibroblasts; Fluorescent Dyes; Humans; Interleukin-1; Lipoprotein Lipase; Membrane Lipids; Microscopy, Fluorescence; Oleic Acid; Palmitic Acid; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Platelet-Derived Growth Factor; Propranolol; Pyrimidinones; Thiazoles | 1997 |
Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB.
Topics: 4-Chloro-7-nitrobenzofurazan; Blotting, Western; Deoxyglucose; Enzyme Activation; Fibroblast Growth Factors; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; I-kappa B Kinase; Insulin; Insulin Resistance; MAP Kinase Kinase 4; Muscle Fibers, Skeletal; NF-kappa B p50 Subunit; Palmitic Acid; Phosphorylation; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction | 2012 |